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Abstract 
The isolated bladder shows autonomous micromotions, which increase with bladder 
distension, generate sensory nerve activity, and are altered in models of urinary 
dysfunction. Intravesical pressure resulting from autonomous activity putatively reflects 
three key variables; the extent of micromotion initiation, distances over which 
micromotions propagate, and overall bladder tone. In vivo, these variables are 
subordinate to the efferent drive of the central nervous system. In the micturition cycle 
storage phase, efferent inhibition keeps autonomous activity generally at a low level, 
where it may signal “state of fullness” while maintaining compliance. In the voiding 
phase, mass efferent excitation elicits generalized contraction (global motility initiation). 
In lower urinary tract dysfunction, efferent control of the bladder can be impaired, for 
example due to peripheral “patchy” denervation. In this case, loss of efferent inhibition 
may enable unregulated micromotility, and afferent stimulation, predisposing to urinary 
urgency. If denervation is relatively slight, the detrimental impact on voiding may be low, 
as the adjacent innervated areas may be able to initiate micromotility synchronous with 
the efferent nerve drive, so that even denervated areas can contribute to the voiding 
contraction. This would become increasingly inefficient the more severe the 
denervation, such that ability of triggered micromotility to propagate sufficiently to 
engage the denervated areas in voiding declines, so the voiding contraction increasingly 
develops the characteristics of underactivitybecomes increasingly underactive. In 
summary, reduced peripheral coverage by the dual efferent innervation (inhibitory and 
excitatory) impairs regulation of micromotility initiation and propagation, potentially 
allowing emergence of overactive bladder and, with progression, detrusor underactivity. 
Introduction 
Urodynamic testing in a healthy human demonstrates low detrusor pressure during 
filling, with no large phasic contractions and overall high compliance. The voiding phase 
is characterised by an adequate flow, generated by an increase in pressure of suitable 
amplitude. Bladder emptying should be complete and achieved in a reasonable time 
scale. Detrusor overactivity (DO) is defined by the International Continence Society 
(ICS) as the presence of phasic bladder contractions during filling which may be 
spontaneous or provoked (1). Detrusor underactivity (DUA) is a contraction of reduced 
strength and/or duration, resulting in prolonged bladder emptying and/or a failure to 
achieve complete bladder emptying within a normal time span. The recognition that 
these may co-exist in the same person is established (2); originally this situation was 
termed “detrusor hyperactivity with impaired contractile function”, but in ICS 
standardised terminology it signifies the presence of both DO (overactivity during 
storage) and DUA (underactivity during voiding) (Figure 1). 
 
Attempting to explain the underlying pathophysiological processes for DO and DUA to 
co-exist in the same person requires an insight into how pressure is generated within 
the bladder, since both DO and DUA are observations characterised by their pressure 
changes seen during urodynamics (1). In DO, these are involuntary increases of 
pressure during storage, in DUA inadequate voluntary increases of pressure during 
voiding. Thus, the increases of intravesical pressure may have different origins in these 
two co-existing pathologies, the basis of which are potentially crucial when seeking to 
understand the pathophysiology of lower urinary tract dysfunction.  
Autonomous bladder micromotility 
The recognisable existence of autonomous bladder activity, and the associated 
micromotions (3, 4), suggests this is a physiological property, which may contribute to 
key storage phase symptoms such as urgency (5). Recent years have seen extensive 
research into the concept of autonomous bladder activity, and the associated 
micromotions (3, 4) and how they may contribute to key storage phase symptoms such 
as urgency (5). Micromotions have now been comprehensively catalogued during 
experiments in which the bladder is isolated from the host animal and placed under 
physiological conditions. Several research groups haveThis has been evaluated this in 
small animal species (e.g. mouse, rat, guinea pig), using organ baths with transmural 
perfusion (6-8). Arterial perfusion methods have also been developed to evaluate the 
same properties in the bladder of large animals such as the pig (9, 10). It is also 
possible to detect discrete contractile units within the overall force generation using 
frequency analysis of contractions in isolated muscle strips (11), which can be altered 
by extrinsic pharmacological influences (12).  
Micromotions in the isolated bladder have the following properties (Figure 2); 
• They can be focal or propagating; 
• Contractions may involve a varying amount of the bladder wall, in some cases 
over 50% of the total area (8); 
• They generate phasic fluctuations of intravesical pressure, which are 
superimposed on any tonic contraction elicited by agonist exposure; 
• They are enhanced by stimulation (either by increasing the intravesical volume or 
by extrinsic application of agonists);  
• Exaggerated micromotions are seen in animal models of lower urinary tract 
pathologies, for example the isolated bladder from a rat which has previously had 
a period of partial bladder outlet obstruction (BOO) (8) and following spinal cord 
injury (13) 
• The distortions resulting from the autonomous micromotions generate afferent 
nerve activity (14, 15).  
Relationship of micromotions to intravesical pressure 
A very pertinent observation is the fact that the amplitude of micromotion activity does 
not necessarily correlate with the amplitude of associated pressure change within the 
bladder lumen. Specifically, small movements can generate obvious pressure changes 
(9). Conversely, quite large movements may be associated with only small pressure 
fluctuations, which would be below the threshold considered detectable within the 
clinical setting (e.g. 0.5 cm H2O) (9) .  
We hypothesised that three fundamental properties determine how intravesical pressure 
is affected by intrinsic bladder micromotility.  
• If micromotions are absent they clearly cannot influence pressure, so the first key 
property is the initiation of autonomous contractile activity.  
• Secondly, if the movements are initiated but confined to a very small area, their 
effect on pressure is likely to be negligible. Thus the extent and rate of 
micromotion propagation is a key factor.  
• Thirdly, it is clear that non-contracting parts of the bladder with low intrinsic tone 
could dissipate wall tension generated from adjacent micromotions. This would 
mean that micromotion contractions would in effect be damped, and thus 
attenuate intravesical pressure changes, even for relatively large localised 
movements.  
In summary, the ability of micromotility to generate intravesical pressure changes is 
determined by the initiation and propagation of the micromotions, and the overall 
contractile tone of the bladder wall.  
It is important to understand how micromotions are initiated and there is now clear 
recognition of several functional influences within the bladder wall potentially able to 
generate or modulate detrusor activity, including interstitial cells and the urothelium. The 
suburothelium, which includes a functional syncytium of interstitial cells connected by 
gap junctions, expresses Ca2+ waves which influence the spontaneous contractions of 
subjacent muscle (16, 17). The presence of niflumic acid-sensitive Ca2+-activated Cl- 
channels (Anoctamin-1) on interstitial cells modulates the frequency of muscle 
contractions in young rodents (18). Interstitial cell inhibition may thus be a means to 
reduce initiation of micromotility. Adrenergic stimulation to lower the overall muscle tone 
of the bladder wall reduces the phasic pressure fluctuations in the bladder (19), possibly 
by reducing overall tone of the bladder wall. Finally, propagation of electrical activity is a 
well-characterised feature of isolated bladder physiology (20), which is probably 
mediated by gap junctions (21). gGap junction blockade, with agents such as 18β-
glycyrrhetinic acid, attenuates propagation and consequently leads to reduction of 
amplitude of the micromotions and associated pressure fluctuations (22). This 
congruent reduction in the intravesical pressure changes detected with individual 
micromotions by manipulation of micromotion initiation, microcontraction propagation 
and general bladder tone at any given moment are key factors determining whether 
autonomous bladder activity results in proportionate intravesical pressure fluctuations. 
In several species, phasic pressure changes can be seen during the storage phase of 
normal healthy animals. These are generally termed non-voiding contractions (NVCs) 
(23), or non-micturition contractions, and altered frequency or amplitude of such activity 
is seen with bladder filling, especially at higher bladder volumes (24). Alterations are 
clearly evident in animal models. For example, NVCs have been evaluated in spinal 
canal stenosis (a model of detrusor underactivity (25)), and irritant instillation (a model 
of detrusor overactivity (26)). Furthermore, changes in expression of NVCs can 
influence the transition from storage to voiding phase (27). Thus, insight into the 
intracellular pathways (for example role of protein kinase C (28)) and intercellular 
communication (for example electrical propagation (20, 21)) potentially provide direct 
insight into urodynamic properties and lower urinary tract dysfunction.  
Regulation and dysregulation of bladder micromotility in vivo 
Normal regulation of micromotility 
In the intact animal, the autonomous behaviour of the lower urinary tract is subordinate 
to the imposed behaviour determined by the efferent innervation. Clearly, excitatory 
efferent innervation is responsible for generating a globalised bladder contraction at the 
time of voiding. In a well-innervated bladder, the simultaneous activation of all efferent 
nerves results in synchronised contraction of all parts of the bladder wall. Thus, 
micromotion initiation, and by inference the bladder wall tone, are maximal for efficient 
expulsion of urine.  
Rodents exhibit NMCs NVCs during the storage phase, which can be observed 
urodynamically in conscious, anaesthetised and decerebrate animals (19, 29, 30). 
Importantly, the NMCs NVCs become substantially enhanced in amplitude when the 
brain-stem becomes non-functional, and this appears to be a result of loss of tonic 
central inhibition of autonomous activity arising in the bladder wall (19). This is probably 
the explanation for the high prevalence of DO in many patients with neurological 
disease. Thus, understanding of the expression of storage phase micromotions requires 
consideration of the efferent inhibitory CNS influences that reduce peripheral 
micromotility. Precisely where such influences may be active needs further research, 
and may be within the peripheral ganglia or the bladder wall, where they may serve to 
reduce initiation and/or propagation of micromotility, or general bladder tone. Overall, 
efferent inhibition appears to down-regulate the extent of localised activity without 
eliminating it altogether.  
In theory, varying the strength of efferent inhibition could be a feature of the intermittent 
awareness of bladder filling state people normally experience during the storage phase. 
Generally, an individual is not aware of the bladder filling state, but sporadically they 
perceive sensations which are categorised as first sensation of filling, normal desire to 
void and strong desire to void in urodynamic terminology (31). This could reflect a 
general suppression of micromotions by efferent inhibition, corresponding with the 
overall time where people are not specifically aware of their bladder, and occasions in 
which a transient reduction of efferent inhibition could allow slightly increased 
expression of motility. These occasions of transient increase in motility might then 
generate afferent stimulation (14, 15) proportionate to the bladder volume (32), and 
hence enhanced sensory reporting of filling state. Since this low level motility would be 
asynchronous, there would be little detectable pressure change, and the compliance of 
the bladder would be unaffected.  
Overactive bladder and detrusor overactivity 
A common feature of many lower urinary tract dysfunctions is the presence of 
denervation. In fact, the patchy denervation pattern seen in DO was suggested to be a 
general defining feature (33), and has been described in idiopathic (34), obstructive (35) 
and neurogenic (36) detrusor overactivity. This patchy nerve loss pattern has been 
mapped in three-dimensional image reconstructions and shows a consistent anatomical 
arrangement throughout the length of detrusor muscle bundles (37). Implicitly, the loss 
of local innervation would prevent the effects of efferent influences during storage and 
voiding (Figure 3). Where efferent inhibitory influence is impaired, denervated areas 
would be better able to express spontaneously their autonomous micromotility during 
the storage phase. This may lead to DO if the condition of the bladder wall in terms of 
motility propagation and tone support the spread of excitation and transmission of force. 
Alternatively, increased amplitude of localised motility with minimal effect on pressure 
may be another pattern, as has been described in some women with urinary urgency in 
the absence of DO (38). This situation may signify increased initiation, with short 
propagation and/ or low tone.  
The symptoms associated with altered micromotions would be affected by the extent of 
preservation of afferent nerves. If afferents are well preserved, the increased 
micromotility would result potentially in increased filling sensation. If the afferent 
innervation is impaired along with the efferent, then reduced sensation may occur.  
In prenatal and neonatal rodents, large amplitude micromotions help expel urine from 
the bladder when neuronal innervation is not yet complete (16). This activity can 
contribute to a spinal cord to bladder reflex where voiding can be initiated by perigenital 
stimulation (39, 40). In infants, voiding is also partly reflexive, occurring when the 
bladder is full (41). After neuronal innervation is complete, reflex activity and 
micromotions disappear but can re-emerge in pathologies including spinal cord injury 
and chemical cystitis. This has been demonstrated in whole bladder sheet preparations 
where single-unit afferent nerve firing and tension are simultaneously recorded (Figure 
4). With spinal cord transection, supraspinal inhibition is removed (42) and large 
amplitude micromotions develop that can stimulate afferent nerves (15) to trigger reflex 
voiding as well as the local release of neuropeptides. These large amplitude 
micromotions require overdistension, as they are prevented by urinary diversion (17), 
and an intact mucosa, as its removal abolishes this activity (43). In chemical irritation 
with acetic acid, where overdistension does not occur and large amplitude micromotions 
do not develop, afferents are sensitized such that low amplitude micromotions can 
stimulate afferent firing (Figure 4B-C). A safe and effective treatment to inhibit 
micromotions has not yet been demonstrated. However, there are indicators that the 
main drugs used clinically to treat overactive bladder can influence this type of activity. 
For example, 3-adrenergic receptor agonists (44, 45) and antimuscarinics (11, 44) 
reduce non-voiding contractions in a rodent model of storage overactivity.. However, the 
sensitivity of afferent nerves can be dampened with botulinum neurotoxin (46) and 3-
adrenergic receptor agonists (A. Kanai, unpublished observations), and these can be 
surmised to treat micromotion-driven bladder overactivity.  
Micromotions in patients with detrusor underactivity 
DUA is a complex and poorly understood urodynamic observation, but it is worth 
considering how the initiation and propagation of bladder micromotions are likely to be 
relevant factors for pressure generation during voiding. In a normal bladder with full 
efferent innervation, voiding is associated with powerful excitation and reduced 
inhibition, so that initiation and tone will be high in the entire organ. For the fully-
innervated bladder, propagation may not be a particular consideration in voiding. 
However, in those individuals with denervation, the ability to initiate contractions will be 
reduced in the denervated areas; thus denervated areas may only contract if there is 
propagation of excitation from a neighbouring innervated area, possibly via interstitial 
cells that are also present between detrusor muscle bundles. The potential for 
propagation of micromotions to recruit contraction in denervated areas during voiding 
may allow compensation for some loss of innervation. Thereby, people with the patchy 
denervation pattern characteristic of DO could maintain seemingly normal voiding, even 
though compensatory mechanisms are involved. Voiding in such people would 
comprise direct efferent stimulation of innervated areas, and indirect stimulation of 
denervated areas, as a result of propagation of excitation from neighbouring innervated 
areas (Figure 3). Consequently, the effect of a small extent of denervation will be 
modest, since denervated areas could deliver some contribution to a voiding 
contraction, even if it is less than that expected with full innervation. Nonetheless, there 
must be some constraints on the extent to which this is possible. Propagation of 
micromotions appears to be relatively slow; in an extensively denervated area, it is likely 
that the time taken to generate a rise in tone and contraction of a denervated area 
would be too long for effective contribution to voiding. Thus, increasing severity of 
denervation will be associated with a reduction in contraction response, and hence 
detrusor underactivity.  
These processes have not been studied in humans with DUA, but in an ageing mouse 
model, there is a clear-cut loss of phasic pressure fluctuations (7), which is associated 
with bladder distension in vivo. 
Summary 
It is proposed that the generation of small intravesical pressure transients depends on 
the initiation and propagation of bladder wall micromotions coupled to a significant 
overall bladder tone. These processes are modulated by the phase of the micturition 
cycle, with efferent inhibition preventing excessive activity during the storage phase and 
efferent excitation ensuring synchronous activation of all areas during voiding. In 
situations where innervation is impaired, the influence of central nervous efferents on 
this activity is altered; the emergence of autonomous activity is seen during urine 
storage, due to loss of efferent inhibition. During voiding, loss of efferent excitation may 
be partly compensated by propagation of micromotions from the innervated areas, but 
not where denervation is too extensive (or if gap junctions are sparse). The extent to 
which aberrant micromotions generate sensation may be determined by whether 
afferent nerves are preserved.  
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Figure legends 
Figure 1; End of the filling cystometry and the pressure flow study (PFS) from a 38 year old 
man where DO with DUA is present. 1. Detrusor overactivity; 2. Time of maximum flow rate in 
PFS (maximum flow rate is 11 ml/sec, detrusor pressure 30 cm H2O, so bladder contractility 
index is 85, indicating impaired contractility); 3. The subject undertakes abdominal straining to 
supplement the poor contractile function); 4. Cough-subtraction at the end of the void is 
adequate. Overall duration of voiding phase was 100 seconds, and a post void residual was 
present.  
Figure 2; A schematic approach to representing a 3-dimensional bladder in 2-D. Much like the 
earth’s globe (A) can be represented as a 2-D map (B), the intact bladder (C) can be portrayed 
schematically in 2-D (D), incorporating landmarks (trigone, urethra, ureters and nerve trunks. 
This illustration conveys the propagating pattern of micromotility, yellow indicating motile, and 
stars indicating initiation points of the microcontractions.  
Figure 3; Two-dimensional representation of the possible impact of denervation on the bladder 
in an intact animal. TOP ROW; The innervation shown heading towards the trigone is marked 
with a minus (-), to signify efferent inhibition as present in the storage phase. A. Where 
innervation is complete, the entire bladder is effectively inhibited to facilitate storage. B. Where 
there is mild, patchy denervation, the affected areas are able to express some autonomous 
activity, and consequently OAB/ DO. C. Severe denervation increases the propensity to 
autonomous micromotility. BOTTOM ROW; The same bladders, but during the voiding phase 
(innervation +). A. The fully innervated bladder shows consistent, coherent contraction of the 
entire bladder wall simultaneously. B. The presence of partial denervation is compensated by 
the triggering from the adjacent edges where (innervated) patches are stimulated by the 
innervation. C. The sheer extent of denervation prevents the triggering from innervated areas 
generating sufficient contraction of the denervated areas to contribute usefully, resulting in 
detrusor underactivity. 
Figure 4. Schematic diagram of an in vitro recording chamber for the measurement of rat 
bladder tension and afferent nerve activities. The urinary bladder is isolated with its associated 
L6-S2 spinal roots and lumbar splanchnic nerve which carry the pelvic and hypogastric afferent 
nerves, respectively. Detrusor contractile activity is monitored through a tension transducer 
which is connected to a stepper motor to stretch and elicit mechanical stimulation. Nerves are 
split in the oil baths to allow recording of mechanosensitive afferents that respond to 
micromotion-induced bladder stretch, as well as nociceptors that fire spontaneously, with single-
units (at the arrows) determined by off-line analysis. B. Under normal conditions, micromotions 
do not generate significant changes in tension as reflected by the lack of afferent nerve firing 
from the S1 spinal nerves. C. Addition of 0.1% acetic acid to the bladder bath enhanced 
micromotions which, combined with sensitization of the afferent nerves, triggered robust firing. 
 
